Le Lézard
Subjects: Photo/Multimedia, Conference

The American Journal of Managed Care® Hosts ?The Challenges and Treatment of Sickle Cell Disease' Panel Discussion


The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, presents its most recent "Peer Exchange" panel discussion, "The Challenges and Treatment of Sickle Cell Disease."

"Although there are some effective treatments that can minimize SCD symptoms and prolong life, our panel of experts, led by Dr. Neil Minkoff, will explore current treatment regimens and discuss other emerging therapies for the treatment of SCD," said Michael J. Hennessy Jr., president of MJH Life Sciencestm, parent company of AJMC®.

This AJMC® "Peer Exchange" panel will feature four distinguished experts:

The "Peer Exchange" will begin with an in-depth overview of SCD that defines the difference between sickle cell trait and SCD, as well as the genetic predisposition of SCD. Current treatment options for patients with SCD will be discussed, including the role of hydroxyurea in the pathophysiology of SCD, the mechanism of action of L-glutamine in treating SCD, blood transfusion therapy and hematopoietic stem cell transplantation. Challenges in the management of SCD will also be shared from a multitude of perspectives. Finally, a review of the emerging agents will be presented.

For more information and to view the video series, click here.

About?The American Journal of Managed Care®

The American Journal of Managed Care®?(AJMC®) is a multimedia peer-reviewed, MEDLINE-indexed journal that keeps industry leaders on the forefront of health policy by sharing digital research relevant to industry decision-makers. Other brands in the?AJMC®?family include?The American Journal of Accountable Care®,?Evidence-Based Oncologytm and?Evidence-Based Diabetes Managementtm. These comprehensive multimedia brands bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. AJMC® is a brand of MJH Life Sciencestm, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.



News published on 19 september 2019 at 11:50 and distributed by: